Alphadyne Asset Management’s AbbVie ABBV Stock Holding History

Alphadyne Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.7M	Sell	21,600 -5,200	-19%	-$1.15M	0.08%	301
2025 Q4	$6.12M	Buy	26,800 +17,400	+185%	+$3.96M	0.14%	109
2025 Q3	$2.18M	Buy	+9,400	New	+$1.91M	0.18%	131
2023 Q4	–	Sell	-44,800	Closed	-$6.68M	–	31
2023 Q3	$6.68M	Buy	44,800 +31,400	+234%	+$4.61M	0.51%	47
2023 Q2	$1.81M	Buy	+13,400	New	+$1.97M	0.22%	44

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alphadyne Asset Management's ABBV Position: Q1 2026 in Review

Alphadyne Asset Management opened a new position in AbbVie (ABBV) in Q1 2026: 3,940 shares worth $857K. The stake represents 0.01% of the portfolio and ranks #599 among its holdings. This is a return to the name: Alphadyne Asset Management previously reported a position in ABBV as recently as Q3 2023.

Alphadyne Asset Management first reported a position in ABBV in Q2 2023 and has held it in 3 quarters since. The position peaked at $1.56M in Q3 2023. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Alphadyne Asset Management held 3,940 shares of AbbVie worth $857K as of Q1 2026.
AbbVie was a new Alphadyne Asset Management position in Q1 2026.
AbbVie made up 0.01% of Alphadyne Asset Management's portfolio in Q1 2026, its #599 holding.
Alphadyne Asset Management first reported a position in AbbVie in Q2 2023 and has held it in 3 quarters since.
Alphadyne Asset Management's AbbVie position peaked at $1.56M in Q3 2023.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Alphadyne Asset Management's 13F filing for Q1 2026, filed 15 May 2026.